NanoViricides Inc (NNVC)

[Ubertino]

NanoViricides Anti EKC Drug Candidate to be examined in Japan

Jan - 22 2015

Tsubota is currently Professor and Chairman, Department of Ophthalmology, Keio University School of Medicine in Tokyo, NanoViricides ‘ study of clinical efficacy EkcCide, very important to your study conclusively demonstrated clearance of the severe conjunctivitis symptoms, said Dr. Tsubota, after a conversation with the social scientists at a meeting in Boston last week. He explained, EKC and herpes virus infections of the eye are important medical problems in Japan and Japanese pharmaceutical companies have a strong interest in potential treatments, He continued by saying, I am excited about the opportunity to confirm the studies have in Japan. This is the first step to obtaining Japanese approval. ‘ Anti – EKC Drug Candidate to be examined in Japan, that an internationally renowned Japanese ophthalmologist and corneal researcher Kazuo Tsubota has agreed to confirmatory animal efficacy studies of nanoviricide anti – EKC drug candidate, EKC – Cide against EKC lead in Japan.

http://www.alanmwebber.com/nanoviricides-anti-ekc-drug-candidate-to-be-examined-in-japannanoviricides.html